Spinocerebellar Ataxia 3 (SCA3) Patient with Peripheral Neuropathy

Siti Aminah Sobana, Iin Pusparini, Nushrotul Lailiyya, Ahmad Rizal Ganiem, Uni Gamayani, Yusuf Wibisono, Fathul Huda, Yunia Sribudiani, Tri Hanggono Achmad


Spinocerebellar ataxia (SCA) 3 is a neurodegenerative disease which involves cerebellum and extra cerebellum. Neuropathy in SCA3 manifests in various ways, including axonal and demyelination lesions in sensory and motor nerves. There has not been any study that describes the peripheral neuropathy characteristics of SCA3 patients in Indonesia at the time of this publication. This paper reports a case of a 43-year-old male with known spinocerebellar ataxia 3 presented with hereditary ataxia and mild numbness in both palms since two years before. No abnormalities were found during the sensory examination. The NCS showed severe axonal demyelinating sensorimotor peripheral neuropathy. In magnetic resonance imaging (MRI), an atrophy in the cerebellum with cerebral multiple lacunar infarction was identified. Electrophysiological results revealed profound axonal lesion in peripheral nerves. To conclude, peripheral neuropathy in SCA3 represents the dominance of axonal lesions in motor nerves.


NCS, peripheral neuropathy, SCA3

Full Text:



Shakkottai VG, Fogel BL. Clinical neurogenetics: autosomal dominant spinocerebellar ataxia. Neurol Clin 2013;31:987–1007.

Luo L Wang J, Lo RY, Figueroa KP, Pulst SM, Kuo PH, et al. The initial symptom and motor progression in spinocerebellar ataxias. Cerebellum. 2017;16(3):615–22.

van de Warrenburg BP, Notermans NC, Schelhaas HJ, van Alfen N, Sinke RJ, Knoers NV, et al. Peripheral nerve involvement in spinocerebellar ataxias. Arch Neuronal. 2004;61(11):1757–60.

Perkins B, Bril V. Electrophysiologic testing in diabetic neuropathy. Handb Clin Neurol. 2014;126:235–48.

Bril V, Perkins BA. Validation of the Toronto clinical scoring system for diabetic polyneuropathy. Diabetes Care. 2002;25(11):2048–52.

Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717–20.

Velázquez-Perez L, Rodríguez-Labrada R, Canales-Ochoa N, Sanchez-Cruz G, Fernandez-Ruiz J, Montero JM, et al. Progression markers of spinocerebellar ataxia 2. a twenty years neuphysiological follow up study. J Neurol Sci. 2010;290(1–2):22–6.

Jacobi H Rakowicz M, Rola R, Fancellu R, Mariotti C, Charles P, et al. Inventory of Non-Ataxia Signs (INAS): validation of a new clinical assessment instrument. Cerebellum. 2013;12(3):418–28.

Linnemann C, Tezenas du Montcel S, Rakowicz M, Schmitz-Hübsch T, Szymanski S, Berciano J, et al. Peripheral neuropathy in spinocerebellar ataxia type 1, 2, 3, and 6. Cerebellum. 2015;15(2):165–73.

Escorcio Bezerra ML, Pedroso JL, Pinheiro DS, Braga-Neto P, Povoas Barsottini OG, Braga NI, et al Pattern of peripheral nerve involvement in machado-joseph disease: neuronopathy or distal axonopathy?. a clinical and neurophysiological. Eur Neurol. 2013;69(3):129–33.

Pardo ID, Rao DB, Butt MT, Jortner BS, Valentine WM, Arezzo J, et al. Toxicologic pathology of the peripheral nervous system (pns): overview, challenges, and current practices. Toxicol Pathol. 2018;46(8):1028–36.

Abele M, Bürk K, Andres F, Topka H, Laccone F, Bösch S, et al. Autosomal dominant cerebellar ataxia type i: nerve conduction and evoked potential studies in families with SCA1, SCA2, and SCA3. Brain. 1997;120(Pt 12):2141–8.

Coutinho P, Guimarães A, Pires MM, Scaravilli F. The peripheral neuropathy in machado-joseph disease. Acta Neuropathol. 1986;71(1-2):119–24.

Lin KP, Soong BW. Peripheral neuropathy of machado joseph disease in Taiwan: a morphometric and genetic study. Eur Neurol. 2002;48(4):210–7.

Suga N, Katsuno M, Koike H, Banno H, Suzuki K, Hashizume A, et al. Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3. Neuropathol Appl Neurobiol. 2014;40(5):628–39.

Prior R, Van Helleputte L, Benoy V, Van Den Bosch L. Defective axonal transport: a common pathological mechanism in inherited and acquired peripheral neuropathies. Neurobiol Dis. 2017;105:300–20.

Duncan ID, Radcliff AB. Inherited and acquired disorders of myelin: the underlying myelin pathology. Exp Neurol. 2016;283:452–75.

Velázquez Pérez L, Sánchez Cruz G, Canales Ochoa N, Rodríguez Labrada R, Rodríguez Díaz J, Almaguer Mederos L, et al. Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2. J Neurol Sci. 2007;263(1-2):158–64.

Graves TD, Guiloff RJ. SCA3 presenting as an isolated axonal polyneuropathy. Arch Neurol. 2011;68:653–5.

Lau KK, Lam K, Shiu KL, Au KM, Tsoi TH, Chan AY, et al. Clinical features of hereditary spinocerebellar ataxia diagnosed by molecular genetic analysis. Hong Kong Med J. 2004;10(4):255-9.

DOI: https://doi.org/10.15395/mkb.v54n1.2394

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


This Journal indexed by




Creative Commons License
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License


View My Stats